The History of Snoring Treatment: From Surgery to Smart Devices

Pre-Modern Remedies: Myths, Folklore, and Early Mechanical Fixes

Snoring has been documented as a social and medical problem for as long as written records exist. Ancient Egyptian and Greek texts reference loud nocturnal breathing as a sign of poor constitution or humoral imbalance, and folk remedies ranged from herbal fumigants burned in the sleeping chamber to mechanical devices designed to force the sleeper onto their side. The "anti-supine shirt" — a garment with a hard ball sewn into the back to make lying flat uncomfortable — appeared in various forms across multiple cultures, predating modern sleep science by centuries. The basic logic, discouraging the supine position that worsens airway collapse, was correct even when the underlying anatomy was not understood.

The 19th century brought the first wave of commercial snoring remedies, many of which were of dubious value. Patent medicines claiming to tighten throat tissues, nasal inhalers designed to open airways, and chin straps made of leather or fabric were sold through mail-order catalogs and pharmacies. Most had no clinical basis, but the chin strap in particular contained a kernel of valid biomechanical reasoning — keeping the mouth closed can reduce or redirect airflow in ways that lower snoring intensity for some people. This early intuition would eventually be validated by modern dental sleep medicine.

Surgery was the only intervention with any systematic medical backing prior to the 20th century, and the procedures available were crude by any standard. Uvulectomy — partial or complete removal of the uvula — was performed by some physicians on the theory that the dangling tissue was the primary snoring culprit. While uvular tissue does contribute to snoring sound generation, removing it rarely produced lasting relief because it failed to address the broader airway collapse pattern involving the soft palate, tongue base, and pharyngeal walls.

The 1980s Breakthrough: When CPAP Changed Sleep Medicine

The history of snoring treatment cannot be told without acknowledging the foundational event that transformed the entire field: the development of continuous positive airway pressure therapy by Australian physician Colin Sullivan in 1981. CPAP was not developed for snoring — it was developed for obstructive sleep apnea, a condition that had only recently been characterized as a distinct clinical entity. But its introduction established something previously absent from the field: proof that the sleeping airway could be reliably held open using mechanical means, producing dramatic and measurable improvements in sleep quality and daytime function.

The commercial rollout of CPAP through the 1980s and into the 1990s created the infrastructure that modern sleep medicine is built on: polysomnography labs, home sleep testing, sleep medicine as a recognized specialty, and insurance reimbursement pathways for sleep-disordered breathing. For the first time, patients with severe snoring and sleep apnea had access to a treatment that worked consistently. The limitation was — and remains — compliance. CPAP requires wearing a mask connected to a pressurized air supply every night indefinitely, and adherence rates in clinical populations hover around 50 percent even with active support programs.

The compliance problem created an opening for alternative treatment modalities. Clinicians treating patients who could not tolerate CPAP began exploring oral appliances as a second-line option, setting the stage for the next phase of snoring treatment evolution. According to the American Academy of Dental Sleep Medicine, oral appliance therapy has since been elevated from an alternative to a first-line treatment recommendation for mild to moderate obstructive sleep apnea and primary snoring, supported by a substantial body of clinical evidence accumulated over four decades.

MADs Go Mainstream: Oral Appliance Therapy Enters Clinical Practice

The mandibular advancement device has a longer history than most people realize. The concept of repositioning the lower jaw to open the posterior airway was described in dental literature as early as the 1930s, but it did not enter clinical sleep medicine practice until the 1980s, when the growing awareness of sleep-disordered breathing created demand for CPAP alternatives. Early MADs were custom-fabricated by dentists with specialized training, expensive, and accessible only through dental sleep medicine clinics. Their effectiveness was recognized but their reach was limited.

The 1990s and 2000s brought two parallel developments that accelerated oral appliance adoption. First, clinical trials began producing rigorous evidence that MADs produced meaningful reductions in apnea-hypopnea index scores and snoring intensity in a substantial proportion of patients, establishing an evidence base that could support clinical guidelines and insurance coverage. Second, over-the-counter versions using boil-and-bite thermoplastic materials began reaching consumers through pharmacies and eventually online retail, removing the cost and access barriers that had kept oral appliances in the specialist clinic. The quality gap between custom and OTC devices narrowed considerably as materials science improved.

Tongue stabilizing devices entered the picture as a complement and alternative to MADs, particularly valuable for patients with dental contraindications — missing teeth, certain bite patterns, or TMJ conditions that made mandibular advancement uncomfortable or inadvisable. TSDs work by an entirely different mechanism: a soft bulb that creates gentle suction to hold the tongue forward, preventing it from collapsing into the airway without exerting any force on the jaw or teeth. Clinical evidence for TSDs accumulated more slowly than for MADs, but the Harvard Health review of anti-snoring products confirms both mechanisms have demonstrated efficacy in well-designed trials.

The Surgical Era: UPPP, Radiofrequency, and Laser-Assisted Procedures

Alongside the growth of oral appliance therapy, the 1980s and 1990s also saw the development of a range of surgical procedures aimed at reducing snoring by physically modifying the tissues of the upper airway. Uvulopalatopharyngoplasty, known by the acronym UPPP, became the most widely performed sleep surgery through the 1990s and involved removing the uvula, trimming the soft palate, and excising excess pharyngeal tissue. Initial case series reported high short-term success rates, and UPPP was briefly regarded as a definitive snoring treatment.

Long-term follow-up told a more complicated story. UPPP required general anesthesia and a painful two-to-four week recovery, carried genuine procedural risks including bleeding, infection, and nasopharyngeal regurgitation, and showed declining effectiveness over time as scar tissue formation altered the operated tissues in ways that sometimes worsened airway dynamics. Five-year success rates for primary snoring reduction were considerably lower than initial reports, and the procedure fell out of favor for snoring without documented sleep apnea as less invasive alternatives emerged.

Radiofrequency ablation and laser-assisted uvulopalatoplasty represented the next generation of surgical approaches, trading the single large procedure for a series of office-based treatments that used targeted energy to stiffen and reduce soft palate and uvular tissue volume. These techniques offered significantly lower risk profiles and required only local anesthesia, making them more accessible. They remain options within the sleep surgery toolkit today, though they are generally reserved for patients who have failed oral appliance therapy and CPAP, or who have specific anatomical findings that surgical correction can meaningfully address.

The Digital Revolution: AI Screening, Wearables, and App-Based Diagnosis

The most significant shift in snoring treatment over the past decade has not been a new device or procedure but a transformation in how snoring is detected, characterized, and monitored. Smartphone applications capable of recording and analyzing sleep sounds have put basic snoring assessment within reach of anyone with a modern phone. Apps like SnoreLab and similar tools provide frequency analysis, intensity tracking, and longitudinal data that patients can bring to clinical consultations — a meaningful improvement over the historical standard of a partner's subjective report.

Consumer wearables have added physiological context to acoustic data. Devices that track blood oxygen saturation, heart rate variability, and movement during sleep can flag patterns suggestive of sleep-disordered breathing, prompting users to pursue formal evaluation. The clinical community has been appropriately cautious about the accuracy of consumer-grade oximetry and sleep staging, but the population-level effect of making these measurements accessible has been to increase the number of people who arrive at sleep clinics with actionable data rather than vague complaints.

Artificial intelligence is beginning to enter the diagnostic pipeline in more substantive ways. Machine learning models trained on large polysomnography datasets have demonstrated the ability to characterize snoring sounds with reasonable accuracy by frequency signature — distinguishing nasal from palatal from tongue-base snoring, which has direct implications for treatment selection. If an AI screening tool can reliably identify that a given snorer's primary mechanism is tongue-base collapse, an oral appliance with strong TSD capability becomes the rational first choice rather than a trial-and-error guess. This kind of mechanism-matched treatment selection is where the field is heading.

The 2026 Landscape: Where We Are and What's Coming Next

As of 2026, the snoring treatment landscape offers more options than at any previous point in history, but the fundamental challenge has not changed: matching the right treatment to the right patient mechanism. The proliferation of devices — MADs, TSDs, combination devices, chin straps, nasal dilators, positional trainers, surgical options, and CPAP — has created an abundance of choices without always creating clarity about which choice is best for a given individual. The clinical evidence base strongly favors combination MAD-TSD therapy for most primary snorers without contraindications, and this is the approach the Snorple mouthpiece is built around.

The near-term future of snoring treatment is likely to be defined by two trends: better phenotyping and better personalization. Phenotyping refers to the ability to characterize individual snoring mechanisms with enough precision to predict treatment response — work that is currently being done through advanced polysomnographic analysis, acoustic characterization, drug-induced sleep endoscopy, and AI-assisted screening. Personalization refers to devices and treatments that adapt to individual anatomy and physiology, from thermoplastic mouthpieces that custom-mold to the wearer's dental anatomy to CPAP algorithms that adjust pressure in real time based on detected airway events.

What is already available today — well-designed, adjustable, combination oral appliances made from medical-grade materials — represents a meaningfully better starting point than what was accessible a decade ago. The Snorple Complete System, combining dual-mechanism mouthpiece with an adjustable chin strap, reflects the current clinical consensus that multi-mechanism treatment produces better outcomes than single-mechanism approaches. Understanding this history helps put the current options in context: the progress is real, the remaining limitations are known, and the path forward is increasingly clear.